2018 International Conference on Communication, Computing and Internet of Things (IC3IoT) 2018
DOI: 10.1109/ic3iot.2018.8668141
|View full text |Cite
|
Sign up to set email alerts
|

Recognition and Arrangement of Blood Cancer from Microscopic Cell Pictures Utilizing Support Vector Machine K-Nearest Neighbor and Deep Learning

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
2
1
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 15 publications
0
3
0
Order By: Relevance
“…Alongside the usage of imaging techniques, many studies employed other techniques; for example, Moraes et al [ 133 ] suggested the usage of flow cytometry data for distinguishing leukemia/lymphoma, and Mahmood et al [ 143 ] directed their research to focus more on identifying the most discriminatory features for CLL using patient laboratory test results, demographic parameters, and training a Classification and Regression Trees model on 94 pediatric patients, which was evaluated using 10-fold cross validation. Moreover, both Dharani and Hariprasath [ 31 ] and Jagadev and Virani [ 34 ] used SVM to classify leukemia and its subtypes, while Paswan and Rathore [ 28 ] used K-nearest neighbors to separate blasted blood cells from normal ones and classify them further into either AML or ALL using a value of K=4. By contrast, Moraes et al [ 133 ] suggested the implementation of decision tree as an ML-based technique for distinguishing leukemia/lymphoma, where a binary classification between healthy and immature leukocytes was performed with an 80%/20% data split, followed by a subclassification of immature leukocytes into their respective 4 types using a 70%/30% split, and several combinations of hyperparameters were evaluated during a 5-fold cross validation.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Alongside the usage of imaging techniques, many studies employed other techniques; for example, Moraes et al [ 133 ] suggested the usage of flow cytometry data for distinguishing leukemia/lymphoma, and Mahmood et al [ 143 ] directed their research to focus more on identifying the most discriminatory features for CLL using patient laboratory test results, demographic parameters, and training a Classification and Regression Trees model on 94 pediatric patients, which was evaluated using 10-fold cross validation. Moreover, both Dharani and Hariprasath [ 31 ] and Jagadev and Virani [ 34 ] used SVM to classify leukemia and its subtypes, while Paswan and Rathore [ 28 ] used K-nearest neighbors to separate blasted blood cells from normal ones and classify them further into either AML or ALL using a value of K=4. By contrast, Moraes et al [ 133 ] suggested the implementation of decision tree as an ML-based technique for distinguishing leukemia/lymphoma, where a binary classification between healthy and immature leukocytes was performed with an 80%/20% data split, followed by a subclassification of immature leukocytes into their respective 4 types using a 70%/30% split, and several combinations of hyperparameters were evaluated during a 5-fold cross validation.…”
Section: Discussionmentioning
confidence: 99%
“…Values, n (%) Pathway stage [1,6,7,29,38,40,41,50,51,53,55,64,69,82,92,94,96,[99][100][101][102]105,117,118,136,143,144] 27 (20.6) Prediction [3,10,28,30,[32][33][34]36,[44][45][46]57,58,61,66,71,72,[76][77][78]80,83,85,89,91,…”
Section: Studiesmentioning
confidence: 99%
“…Methodologies such as liquid biopsy, which includes extracting circulating tumor DNA or other cancer-related components from blood, provide a minimally invasive method but still a painful and discomforting procedure for the patient [6][7][8]. Furthermore, advances in imaging techniques, such as high-resolution imaging and molecular imaging, allow clinicians to view changes in blood cells and tissues in a non-invasive manner, aiding in the early detection of blood cancer [9][10][11]. Utilizing these non-invasive methods, healthcare providers can diagnose blood cancer in its early stages, allowing for timely treatment and improved patient health.…”
Section: Introductionmentioning
confidence: 99%